Does sugammadex facilitate recovery after outpatient tonsillectomy in children?

Peer review under responsibility of Egyptian Society of Anesthesiologists.

Figures & data

Table 1 Demographic data of the studied groups.

Demographic data	Control group (N) (n = 35)	Sugammadex group (S) (n = 35)	p-value
Age (years)	5.42 ± 2.23	5.64 ± 2.41	0.693^⁎
Gender
Male	16 (45.7%)	17 (48.6%)	0.811^§
Female	19 (54.3%)	18 (51.4%)
Weight (kg)	15.24 ± 8.92	14.42 ± 10.65	0.728^⁎
Time of surgery (min)	33.62 ± 8.51	31.97 ± 4.75	0.315^⁎
Rocuronium (mg)	9.12 ± 5.34	8.64 ± 7.59	0.760^⁎

n = Total number of patients in each group; quantitative data were expressed as the mean ± SD; qualitative data were expressed as a number (percentage).

⁎ Mann Whitney U test.

§ Chi-square test; p < 0.05 is significant.

Table 2 The times from last NMB, reversal agent administration to Extubation.

Time	Control group (N) (n = 35)	Sugammadex group (S) (n = 35)	p-value
Time for applying neostigmine or sugammadex after the last NMB (min)	25.54 ± 21.36	25.84 ± 21.45	0.953^⁎
Time from the last NMB to extubation (min)	29.14 ± 20.34	26.23 ± 22.32	0.571^⁎
Extubation time (min)	4.21 ± 1.18	1.25 ± 0.59	<0.001^⁎

n = Total number of patients in each group; quantitative data were expressed as the mean ± SD.

⁎ Mann Whitney U test; p < 0.05 is significant.

Table 3 The TOF ratio evaluation.

TOF ratio	Control group (N) (n = 35)	Sugammadex group (S) (n = 35)	p-value^⁎
TOF ratio before reversing	39.16 ± 20.65	32.54 ± 20.84	0.186
TOF ratio after reversing	83.21 ± 1.16	91.25 ± 0.56	<0.001^⁎
The time when TOF rate exceeded 0.9 min	1.64 ± 2.59	0.41 ± 0.58	0.007^⁎

n = Total number of patients in each group; quantitative data were expressed as the mean ± SD.

⁎ Mann Whitney U test; p < 0.05 is significant.